Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study

OBJECTIVE: To determine the efficacy and safety of etanercept and etanercept plus sulfasalazine versus sulfasalazine in patients with rheumatoid arthritis (RA) despite sulfasalazine therapy. METHODS: Patients were randomly assigned to etanercept (25 mg twice weekly; sulfasalazine was discontinued at...

Descripción completa

Detalles Bibliográficos
Autores principales: Combe, B, Codreanu, C, Fiocco, U, Gaubitz, M, Geusens, P P, Kvien, T K, Pavelka, K, Sambrook, P N, Smolen, J S, Khandker, R, Singh, A, Wajdula, J, Fatenejad, S
Formato: Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2008
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689524/
https://www.ncbi.nlm.nih.gov/pubmed/18794178
http://dx.doi.org/10.1136/ard.2007.087106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689524/
https://www.ncbi.nlm.nih.gov/pubmed/18794178
http://dx.doi.org/10.1136/ard.2007.087106

Ejemplares similares